Industry reports
Editor highlights

Drug and Medication Analysis & Statistics in France, July 2013 (p2)

You might be interested in: drug, vaccine, insulin, more »

» Purchase Premium Reports

31-60 of about 100 reports
PharmaPoint: Postmenopausal Vaginal Atrophy - France Drug Forecast and Market Analysis to 2022

PharmaPoint: Postmenopausal Vaginal Atrophy - France Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • July 2013
  • by Global Data

PharmaPoint: Postmenopausal Vaginal Atrophy - France Drug Forecast and Market Analysis to 2022 Summary Although the postmenopausal vaginal atrophy (PVA) market has experienced anemic growth over the past ...

  • Industries : Drug and Medication
  • Countries : France
France Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

France Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • July 2013
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: With the aim of improving patient safety and restoring confidence in the country’s drug regulatory process, in December 2011 the French parliament approved ...

  • Industries : Drug and Medication
  • Countries : France
NRT Smoking Cessation Aids Market Analysis in France

NRT Smoking Cessation Aids Market Analysis in France

  • $ 898
  • Industry report
  • June 2013
  • by Euromonitor International

However this legislation, put into force some years ago, seems to have reached its limits in terms of impact, as... Euromonitor International's report offers a comprehensive guide to the size and shape ...

  • Industries : Drug and Medication, Tobacco
  • Countries : France
Emergency Contraception Market Analysis in France

Emergency Contraception Market Analysis in France

  • $ 898
  • Industry report
  • June 2013
  • by Euromonitor International

This increase was essentially driven by higher demand, as unit prices were stable. To prevent unplanned pregnancies, in particular after unprotected sex or contraception failure, French women continued ...

  • Industries : Drug and Medication
  • Countries : France
Ear Care Market Analysis in France

Ear Care Market Analysis in France

  • $ 898
  • Industry report
  • June 2013
  • by Euromonitor International

Euromonitor International's report offers a comprehensive guide to the size and shape of the industry at a national level. It provides the latest retail sales data from 2006 to 2010 , allowing you to ...

  • Industries : Drug and Medication
  • Countries : France
Cough, Cold and Allergy (Hay Fever) Remedies Market Analysis in France

Cough, Cold and Allergy (Hay Fever) Remedies Market Analysis in France

  • $ 898
  • Industry report
  • June 2013
  • by Euromonitor International

In general, consumers are used to self-medicating with products from this category and they did not change their habits in 2010. However, the category faced stronger competition from some homoeopathic ...

  • Industries : Drug and Medication
  • Countries : France
PharmaPoint: Hepatitis C Virus - France Drug Forecast and Market Analysis

PharmaPoint: Hepatitis C Virus - France Drug Forecast and Market Analysis

  • $ 4 995
  • Industry report
  • May 2013
  • by Global Data

PharmaPoint: Hepatitis C Virus - France Drug Forecast and Market Analysis Summary GlobalData has released its new Country report, ?PharmaPoint: Hepatitis C Virus - France Drug Forecast and Market Analysis?. ...

  • Industries : Drug and Medication
  • Countries : France
PharmaPoint: Hepatitis C Virus - France Drug Forecast and Market Analysis to 2022

PharmaPoint: Hepatitis C Virus - France Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • May 2013
  • by Global Data

PharmaPoint: Hepatitis C Virus - France Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Hepatitis C Virus - France Drug Forecast and Market ...

  • Industries : Drug and Medication
  • Countries : France
PharmaPoint: Psoriasis - France Drug Forecast and Market Analysis to 2022

PharmaPoint: Psoriasis - France Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • May 2013
  • by Global Data

PharmaPoint: Psoriasis - France Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Psoriasis - France Drug Forecast and Market Analysis to ...

  • Industries : Drug and Medication
  • Countries : France
Vaccines - Global Markets Package

Vaccines - Global Markets Package

  • $ 24 060
  • Industry report
  • May 2013
  • by Global Research & Data Services

This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in different countries around the world. The studies provide essential market ...

  • Industries : Drug and Medication
  • Countries : World, Europe, Asia, South America, Czech Republic, South Korea, Philippines, Africa, Australia, Argentina, United States, United Kingdom, Netherlands, Macedonia, Lithuania, Sri Lanka, Singapore, Kazakhstan, Indonesia, Bangladesh, Azerbaijan, South Africa, Uruguay, Ecuador, Chile, Colombia, Bolivia, Panama, Mexico, Canada, Ukraine, Sweden, Spain, Slovenia, Slovakia (slovak Republic), Russian Federation, Romania, Portugal, Poland, Norway, Moldova, Republic Of, Latvia, Italy, Ireland, Hungary, Greece, France, Germany, Finland, Estonia, Denmark, Bulgaria, Belgium, Austria, Thailand, Pakistan, Nepal, Mongolia, Malaysia, Lebanon, Jordan, Japan, India, China, Georgia, Armenia, Sudan, Senegal, Nigeria, Morocco, Ghana, Ethiopia, Egypt, Kyrgyz Republic (kyrgyzstan), North America, Peru, Oman, Iran
Vaccines - Top 10 Global Markets Package

Vaccines - Top 10 Global Markets Package

  • $ 5 174
  • Industry report
  • May 2013
  • by Global Research & Data Services

This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in the top 10 global countries. The studies provide essential market information ...

  • Industries : Drug and Medication
  • Countries : World, United States, United Kingdom, Russian Federation, Italy, France, Germany, Japan, India, China, Europe
Vaccine Market in France

Vaccine Market in France

  • $ 652
  • Industry report
  • May 2013
  • by Global Research & Data Services

This market research report offers a perspective on the actual market situation, trends and future outlook for vaccines in France. The study provides essential market information for decision-makers including: ...

  • Industries : Drug and Medication
  • Countries : France
MarketVIEW: Typhoid travel vaccines

MarketVIEW: Typhoid travel vaccines

  • $ 4 495
  • Industry report
  • April 2013
  • by VacZine Analytics Group Of Assay Advantage Ltd

Typhoid fever is caused by Salmonella typhi bacteria that are transmitted through contaminated food and drink in conditions of poor sanitation. Without prompt treatment with antibiotics typhoid fever can ...

  • Industries : Drug and Medication
  • Countries : World, Australia, Europe, United States, Canada, Spain, Italy, France, Germany, United Kingdom
MarketVIEW: Cholesterol vaccines

MarketVIEW: Cholesterol vaccines

  • $ 8 995
  • Industry report
  • April 2013
  • by VacZine Analytics Group Of Assay Advantage Ltd

Cardiovascular disease(s) (CVD) are prominent within the 10 leading causes of death in high-income countries. The most common manifestations of CVD are coronary heart disease (CHD), ischaemic stroke, and ...

  • Industries : Drug and Medication
  • Countries : Australia, Europe, United States, Canada, Spain, Italy, France, Germany, World, United Kingdom
PharmaPoint: Osteoporosis - France Drug Forecast and Market Analysis to 2022

PharmaPoint: Osteoporosis - France Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • February 2013
  • by Global Data

PharmaPoint: Osteoporosis - France Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Osteoporosis - France Drug Forecast and Market Analysis ...

  • Industries : Drug and Medication
  • Countries : France
PharmaPoint: Epilepsy - France Drug Forecast and Market Analysis to 2022

PharmaPoint: Epilepsy - France Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • February 2013
  • by Global Data

PharmaPoint: Epilepsy - France Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Epilepsy - France Drug Forecast and Market Analysis to 2022?. ...

  • Industries : Drug and Medication
  • Countries : France
PharmaPoint: HIV - France Drug Forecast and Market Analysis to 2022

PharmaPoint: HIV - France Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • January 2013
  • by Global Data

PharmaPoint: HIV - France Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: HIV - France Drug Forecast and Market Analysis to 2022?. Human ...

  • Industries : Drug and Medication
  • Countries : France
Elvitegravir (HIV) - Forecast and Market Analysis to 2022

Elvitegravir (HIV) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • January 2013
  • by Global Data

Elvitegravir (HIV) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Elvitegravir (HIV) - Forecast and Market Analysis to 2022?. Human ...

  • Industries : Drug and Medication
  • Countries : Japan, Brazil, China, World, United States, Spain, Italy, France, Germany, Europe, United Kingdom
The Pharmaceutical Market: France, Business Monitor International

The Pharmaceutical Market: France, Business Monitor International

  • $ 1 337
  • Industry report
  • January 2013
  • by Business Monitor International

Espicom market intelligence, brought to you by Business Monitor International OVERVIEW OF THE PHARMACEUTICAL MARKET IN FRANCE France's high public debt-to-GDP ratio will necessitate more aggressive fiscal ...

  • Industries : Drug and Medication
  • Countries : France
Parkinson`s Disease: World Drug Market 2013-2023

Parkinson`s Disease: World Drug Market 2013-2023

  • $ 2 390
  • Industry report
  • January 2013
  • by Visiongain

Report Details Your guide to sales outlooks and R&D for treating Parkinson's Where are treatments for Parkinson's disease heading - technological and commercial outlooks? Visiongain's updated report gives ...

  • Industries : Drug and Medication
  • Countries : World, United States, Japan, Spain, Italy, France, Germany, United Kingdom, Europe
PharmaPoint: Prostate Cancer - France Drug Forecast and Market Analysis to 2022

PharmaPoint: Prostate Cancer - France Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • December 2012
  • by Global Data

PharmaPoint: Prostate Cancer - France Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Prostate Cancer - France Drug Forecast and Market ...

  • Industries : Drug and Medication
  • Countries : France
Forecast: Pneumococcal Vaccines

Forecast: Pneumococcal Vaccines

  • $ 11 400
  • Industry report
  • December 2012
  • by Datamonitor

This patient-based pneumococcal vaccine forecast segments the market by brand and population groups eligible for vaccination across the US, Japan, and the five major EU markets (France, Germany, Italy, ...

  • Industries : Drug and Medication
  • Countries : Japan, United States, Netherlands, Spain, Italy, France, Germany, Europe, United Kingdom
PharmaPoint: Seasonal Influenza Vaccines France Drug Forecast and Market Analysis

PharmaPoint: Seasonal Influenza Vaccines France Drug Forecast and Market Analysis

  • $ 4 995
  • Industry report
  • November 2012
  • by Global Data

PharmaPoint: Seasonal Influenza Vaccines France Drug Forecast and Market Analysis Summary GlobalData has released its new Country report, ?PharmaPoint: Seasonal Influenza Vaccines France Drug Forecast ...

  • Industries : Drug and Medication
  • Countries : France
EpiCast Report: Seasonal Influenza Vaccines Epidemiology Forecast to 2022

EpiCast Report: Seasonal Influenza Vaccines Epidemiology Forecast to 2022

  • $ 3 995
  • Industry report
  • November 2012
  • by Global Data

EpiCast Report: Seasonal Influenza Vaccines Epidemiology Forecast to 2022 Summary Seasonal Influenza is a respiratory infection caused by influenza virus that results in mild to severe symptoms, such ...

  • Industries : Drug and Medication
  • Countries : Japan, India, China, United States, United Kingdom, Spain, Italy, Germany, France, World, Europe, Asia
Fluarix (Seasonal Influenza Vaccine) Forecast and Market Analysis

Fluarix (Seasonal Influenza Vaccine) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Fluarix (Seasonal Influenza Vaccine) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Fluarix (Seasonal Influenza Vaccine) Forecast and Market ...

  • Industries : Drug and Medication
  • Countries : India, World, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Fluad (Seasonal Influenza Vaccines) Forecast and Market Analysis

Fluad (Seasonal Influenza Vaccines) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Fluad (Seasonal Influenza Vaccines) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Fluad (Seasonal Influenza Vaccines) Forecast and Market Analysis?. ...

  • Industries : Drug and Medication
  • Countries : Spain, France, Germany, World, Italy, Europe, United States, China
Vaxigrip (Seasonal Influenza Vaccines) Forecast and Market Analysis

Vaxigrip (Seasonal Influenza Vaccines) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Vaxigrip (Seasonal Influenza Vaccines) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Vaxigrip (Seasonal Influenza Vaccines) Forecast and Market ...

  • Industries : Drug and Medication
  • Countries : China, World, Italy, France, Germany, India, United Kingdom, Spain, Europe
Optaflu (Seasonal Influenza Vaccine) Forecast and Market Analysis

Optaflu (Seasonal Influenza Vaccine) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Optaflu (Seasonal Influenza Vaccine) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Optaflu (Seasonal Influenza Vaccine) Forecast and Market ...

  • Industries : Drug and Medication
  • Countries : United States, Spain, Italy, France, Germany, World, Europe, United Kingdom
Agrippal (Seasonal Influenza Vaccine) Forecast and Market Analysis

Agrippal (Seasonal Influenza Vaccine) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

Agrippal (Seasonal Influenza Vaccine) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Agrippal (Seasonal Influenza Vaccine) Forecast and Market ...

  • Industries : Drug and Medication
  • Countries : Spain, Italy, Germany, India, China, World, France, Japan, United States, United Kingdom, Europe
FluBlok (Seasonal Influenza Vaccines) Forecast and Market Analysis

FluBlok (Seasonal Influenza Vaccines) Forecast and Market Analysis

  • $ 3 495
  • Industry report
  • November 2012
  • by Global Data

FluBlok (Seasonal Influenza Vaccines) Forecast and Market Analysis Summary GlobalData has released its new PharmaPoint Drug Evaluation report, FluBlok (Seasonal Influenza Vaccines) Forecast and Market ...

  • Industries : Drug and Medication
  • Countries : United States, World, Australia, Spain, Italy, France, Germany, Japan

» View Public Reports

53 reports

Drug and Medication Production and Trade Statistics in The United States and France

  • Industry report
  • December 2012
  • 25 pages

... Endocarditis, a stringent model 73 with long-standing records for evaluation of antibacterial agents, which demonstrated its 74 capacity to predict clinical efficacy in humans, and to discriminate ...


» Read our Company Profiles

1 Companies

GlaxoSmithKline P.L.C.

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.